JCI - The renin-angiotensin system: it's all in your head
The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections | SpringerLink
Targeting the renin−angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges | PNAS
Renin‐angiotensin system revisited - Fyhrquist - 2008 - Journal of Internal Medicine - Wiley Online Library
COVID-19 – Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack? - ScienceDirect
JCI - The plasma kallikrein-kinin system counterbalances the renin-angiotensin system
ACE2 and COVID-19 and the resulting ARDS | Postgraduate Medical Journal
IJMS | Free Full-Text | Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice
Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2) - Annalise E Zemlin, Owen J Wiese, 2020
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm | eLife
Angs (Angiotensins) of the Alternative Renin-Angiotensin System Predict Outcome in Patients With Heart Failure and Preserved Ejection Fraction | Hypertension
High glucose activates the alternative ACE2/Ang‑(1‑7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β‑cells
IJMS | Free Full-Text | COVID-19 and RAS: Unravelling an Unclear Relationship
Frontiers | The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic | SpringerLink
Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
Manipulation of the Renin-Angiotensin System | Circulation
COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease - ScienceDirect
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications | In Vivo
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic | Nature Reviews Nephrology
Frontiers | When Less or More Isn't Enough: Renal Maldevelopment Arising From Disequilibrium in the Renin-Angiotensin System
ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad | European Respiratory Society
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications | In Vivo
